Selpacta 40mg- 80mg

Indication & Dosage :
Selpacta (Selpercatinib), generic  Retevmo is a prescription medicine used to treat certain types of cancer such as non-small cell lung cancer (NSCLC), advanced thyroid cancer, advanced medullary thyroid cancer (MTC) in patients whose tumors have RET fusion-positive genes. Selpercatinib works by slowing or stopping the growth of cancer cells. Selpacta manufactured by Ziska pharma Ltd. In Bangladesh. Selpercatinib has to take orally twice (every 12 hours) daily with/ without food.
Side Effects :
The most common adverse reactions of Selpercatinib are:
Dry mouth, diarrhea, constipation, headache, cough, swelling ankles/feet, nausea, vomiting, or fatigue.The above information comes from the Internet. Please consult with doctor for medical advice.
Suggestion :
* Any advice on the use of the drug is for reference only. Please consult with doctor for medical advice. All Names, logos, trademarks are property of their respective owners. Watermarks, QR code used for identification purposes only.